Question re. the 2007 study
It's great to read that herceptin pre. CNS mets makes for a better prognosis once you get mets, but the abstract didn't say the actual number of women who got CNS mets - if a much higher percent who got CNS mets were her2+ve (with prior Hecept.), then that can put a different interpretation on the article.
My daughter is actually doing her senior project for high school on Her2+ve BC and her thesis title is "Is being Her2+ve still a negative?" - so I'm helping her gather all the "good" info. but as a reference librarian I feel the need to get all the info!
Has anyone read the whole paper of this study?
Best wishes,
Marianne
|